Uncategorized

Dupilumab in COPD: Using AEC as a Biomarker to Break the Hospitalization Cycle

The 2 AM Reality It is 2 AM at the hospital. I am processing an admission for “Mr. B,” a 70 year old with COPD. This is his second admission of 2026, and March has just begun. Mr. B is the “Gold Standard” failure: he is adherent to triple therapy (ICS/LAMA/LABA) and uses his rescue […]

Dupilumab in COPD: Using AEC as a Biomarker to Break the Hospitalization Cycle Read More »